Micro Bio-bots Designed to Deliver Drugs

Corinna Underwood

Corinna Underwood has been a published author for more than a decade. Her non-fiction has been published in many outlets including Fox News, CrimeDesk24, Life Extension, Chronogram, After Dark and Alive.

Micro Bio-bots Designed to Deliver Drugs

In the not-too-distant future, doctors may be able to treat cancer with targeted drugs, delivered by minute “bio-bots,” that swim throughout the human body. The tiny machines are inspired by sperm, are a hybrid combination of live heart cells and synthetic polymer body.

The new bots, developed by researchers from the University of Illinois and Arizona State University, are the first swimming micro-machines that mimic the flagellar movement of sperm. This means they can propel themselves onward, fired by the contractile power of heart cells. The bio-bots are just 2 millimeters long and basically consist of a head and a wire tail with the some live cells to make it functional. The small cluster of heart cells are grown at the intersection of the head and the tail. They are synchronized to beat together, creating a wave motion in the tail that can push the bot forward at a speed of up to 10 micrometers per second.

The bio-bot’s creators have also designed a similar micro-bot with two tails that can swim even faster; up to 81 micrometers per second. According to the team’s lead investigator, Taher Saif, this type of robotic phenomena is the first of its kind, and the team is not quite sure the heart cells manage to communicate with the tail in order for movement to occur. Saif explained that the additional tail allows the bio-bots to navigate. He predicts that future applications could include: chemical detection, light sensing or they could be programmed to reach a specific target for medical or environmental purposes.

While there is still much work to be done, this program marks the innovative first step towards a new realm of bio-hybrid machines. Saif teamed up with fellow University of Illinois researchers Brian J. Williams and Sandeep V. Anand, as well as Arizona State University’s Jagannathan Rajagopalan. Their work was completed as part of Emergent Behaviors in Integrated Cellular Systems (EBICS), a National Science Foundation-funded Science and Technology Center.


Stay Ahead of the AI Curve

Discover the critical AI trends and applications that separate winners from losers in the future of business.

Sign up for the 'AI Advantage' newsletter: